glp-1 gip news Five-target drug beats GLP-1/GIP therapy in obese diabetic mice GLP-1 Pipeline Update: August 2025

Experimental & Molecular Medicine

Q: Where should the injections be stored before use

Muscle is metabolically active, so losing it slows calorie burn

Who should use GLP-1 Medications

are the classical E3 ubiquitin ligases of PPAR (Fig

The other thing were seeing is a lot of companies getting really excited about this idea of helping people who are not on these drugs or are coming off the drugs and needing to control their appetite. Supergut: Interest off the charts following Natures Ozempic positioning One company currently capitalizing on a surge of consumer interest in natural alternatives to GLP-1 drugs is Supergut (formerly Muniq), a startup making bars and shakes containing a blend of resistant starches and prebiotic fibers that are fermented in the gut to produce short chain fatty acids